Basel, July 2, 2026 – Novartis today announced that the European Commission (EC) has approved Itvisma ® (onasemnogene ...
Study published in leading critical care journal shows that higher AI-detected seizure burden is associated with increased odds of disability, further demonstrating the utility of the Ceribell System ...
SUNNYVALE, Calif., June 08, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with ...
The neurological examination has evolved from rudimentary clinical observations in ancient civilizations to a structured and indispensable tool in modern medical diagnostics. Early contributions from ...
Abstract: This article focuses on locating a reflecting target using both bistatic and direct range measurements derived from the propagation delays of signals emitted by a transmitter with unknown ...
Neurological disorders represent a mounting public health crisis in China, exacerbated by rapid population aging. Cerebrovascular diseases and neurodegenerative conditions have become leading causes ...
Neurological disorders represent a mounting public health crisis in China, exacerbated by rapid population ageing. Cerebrovascular diseases and neurodegenerative conditions have become leading causes ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Walter Koroshetz, director of the National Institute of Neurological Disorders and ...
A sudden sensation of numbness? The nagging headache that just won’t quit? That weird weakness in your leg? They’re all symptoms of neurological disorders — a family of conditions that affects more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results